New drug aims to save lives in severe lung failure
NCT ID NCT07208591
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 27 times
Summary
This study tests an experimental drug called STSA-1002 in 406 adults with acute respiratory distress syndrome (ARDS), a life-threatening lung condition often caused by viral infections. Participants receive either the drug or a placebo, and researchers track survival rates and recovery over 28 to 60 days. The goal is to see if the drug reduces deaths and helps patients breathe on their own sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, 100029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dazhou Central Hospital
RECRUITINGDazhou, Sichuan, 635099, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hangzhou First People's Hospital
RECRUITINGHangzhou, Zhejiang, 310006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, Henan, 450003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Affiliated Hospital of Zunyi Medical University
RECRUITINGZunyi, Guizhou, 563000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITINGLuoyang, Henan, 471099, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Xiamen University
RECRUITINGXiamen, Fujian, 361003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, 450052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 51063, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Third Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, 510150, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Weifang People's Hospital
RECRUITINGWeifang, Shandong, 261041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wuhan Central Hospital
RECRUITINGWuhan, Hubei, 430014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangtan Central Hospital
RECRUITINGXiangtan, Hunan, 411100, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.